The Astronaut Health Experiments of Artemis II - Planetary Radio

The Planetary Society
The Planetary SocietyMar 25, 2026

Why It Matters

Understanding how radiation, gravity, and confinement affect astronauts on Artemis II is essential for safe, long‑duration lunar and Martian missions, and the resulting medical advances will benefit health care on Earth.

Key Takeaways

  • Artemis II will test human health beyond Earth’s magnetosphere.
  • NASA’s HRP focuses on radiation, isolation, gravity, distance, environment.
  • Cardiovascular research drives integrated studies of whole-body space effects.
  • New radiation measurements aim to refine models for Moon and Mars.
  • Findings will inform crew safety, medical countermeasures, and Earth benefits.

Summary

The Planetary Radio episode spotlights Artemis II as the first crewed deep‑space flight since Apollo, emphasizing its suite of human‑health experiments. NASA’s Human Research Program (HRP) will fly instruments to measure radiation, cardiovascular function, isolation stress, micro‑gravity adaptation, and cabin environment, aiming to fill data gaps that can only be obtained beyond Earth’s protective magnetosphere.

Chief scientist Dr. Steve Plattz explains the HRP’s five‑hazard framework—Radiation, Isolation, Distance, Gravity, and Environment (RGE‑I‑G‑E). He details how past shuttle and ISS missions revealed blood‑pressure dysregulation, prompting the development of a compression garment, and how cardiovascular expertise naturally informs a systems‑level view of space physiology. The discussion also covers the three radiation categories—solar particle events, galactic cosmic rays, and secondary particles—and why shielding is insufficient for deep‑space missions.

Plattz highlights striking phenomena such as astronauts seeing flashes of light caused by cosmic rays traversing the retina, underscoring the subtle yet pervasive health risks. He notes that Artemis II’s orbital pass will gather real‑time radiation measurements to refine predictive models, and that current mission limits keep crew exposure well below hazardous thresholds, though Mars missions will demand new mitigation strategies.

The implications are profound: data from Artemis II will shape crew‑health protocols for a sustainable lunar presence and future Mars voyages, while the biomedical innovations—like advanced compression suits and radiation‑risk modeling—are expected to spin off into terrestrial healthcare, echoing the historic legacy of space‑driven medical breakthroughs.

Original Description

Artemis II is about more than getting four humans to the Moon and back. It's an opportunity to gather data on human health in deep space that we haven’t had in over 50 years.
This week, we’re joined by Steve Platts, chief scientist of NASA's Human Research Program, who walks us through the suite of human health experiments flying aboard Artemis II, from the ARCHER wearable sensors tracking crew health and team dynamics, to dry saliva swabs measuring stress hormones. Then Casey Dreier, chief of space policy at The Planetary Society, helps us make sense of NASA's Ignition Day, a major press event held on March 24 in which the agency unveiled sweeping changes to its lunar exploration plans and beyond.
And we close with Bruce Betts, chief scientist of The Planetary Society, in our weekly What's Up, where we explore one of the stranger phenomena in human spaceflight, the flashes of light astronauts sometimes see when cosmic rays pass through their eyes.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.

Comments

Want to join the conversation?

Loading comments...